Skip to main content

Miller Lisa K's Form 4 filing

LifeStance Health Group, Inc. (LFST) · filed Nov 25, 2025

Accession no.
0001193125-25-297294
Filed
Nov 25, 2025
Trade date
Nov 21, 2025
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $368.1K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Miller Lisa KCIK 0002036749Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 21, 2025Common StockSSaleDisposed−57,240$6.43F1−$368,053.2261,292Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.41 to $6.50 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

Remarks

Executive Vice President, Practice Operations

Read the full filing on SEC EDGAR (opens in a new tab)